ACRX earnings call for the period ending December 31, 2019.
News & Analysis: AcelRx Pharmaceuticals
ACRX earnings call for the period ending September 30, 2019.
ACRX earnings call for the period ending June 30, 2019.
ACRX earnings call for the period ending March 31, 2019.
The pharma announced first-quarter 2019 operating results.
They could be big winners for patient investors.
Investors wanted more good news than they got in the specialty-drug maker's fourth-quarter update.
These three small-cap stocks have outstanding growth potential.
AcelRx and Novavax are two penny biotech stocks worth checking out in this latest market downturn.
When you invest in a business, you should expect to stay with it for the long haul.